Finance

Explore the landscape of Finance in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finance to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Danatlas Pharmaceuticals Doses First Patient in Phase II Trial of DAT‑2645 – Novel Targeted Therapy for BRCA‑Mutant, HRD‑Positive Ovarian Cancer

Danatlas Pharmaceuticals announced that the first subject has been enrolled and dosed in the Phase II clinical study of DAT‑2645, the company's independently developed Class 1 innovative drug, at the…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.